Pier 88 Investment Partners LLC Recursion Pharmaceuticals, Inc. Transaction History
Pier 88 Investment Partners LLC
- $77.7 Million
- Q3 2025
A detailed history of Pier 88 Investment Partners LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 118,560 shares of RXRX stock, worth $669,864. This represents 0.74% of its overall portfolio holdings.
Number of Shares
118,560
Previous 74,510
59.12%
Holding current value
$669,864
Previous $377,000
53.32%
% of portfolio
0.74%
Previous 0.44%
Shares
6 transactions
Others Institutions Holding RXRX
# of Institutions
366Shares Held
289MCall Options Held
7.75MPut Options Held
6.1M-
Vanguard Group Inc Valley Forge, PA36.1MShares$204 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$186 Million1.38% of portfolio
-
Baillie Gifford & CO24MShares$135 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$97.8 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$82.9 Million0.31% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.02B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...